Home Stock

Stock Research: IQVIA

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

IQVIA

NYQ:IQV US46266C1053
55
  • Value
    60
  • Growth
    67
  • Safety
    Safety
    19
  • Combined
    47
  • Sentiment
    63
  • 360° View
    360° View
    55
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

IQVIA Holdings Inc. is a global provider of clinical research and healthcare intelligence. It operates in Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. In the last fiscal year, the company had a market cap of $27279 millions, profits of $5375 millions, revenue of $15405 millions, and 88000 employees.

more

ANALYSIS: With an Obermatt 360° View of 76 (better than 76% compared with alternatives) for 2026, overall professional sentiment and financial characteristics for the stock IQVIA are very positive. The 360° View is based on consolidating four consolidated indicators, with all but one indicator above average for IQVIA. The consolidated Value Rank has an attractive rank of 59, which means that the share price of IQVIA is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 59% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 70, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth, as well as stock returns. In addition, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 95. But the company’s financing is risky with a Safety rank of 19. This means 81% of comparable companies have a safer financing structure than IQVIA. ...read more

more
Strongest Rank Dividend Yield
Weakest Rank Profit Growth
Country USA
Industry Life Sciences Tools & Services
Size X-Large
Website ir.iqvia.com
Index
D.J. US Health Care
S&P 500
IQVIA stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 26-May-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
60 55 43 41
Growth
67 37 43 79
Safety
Safety
19 4 1 1
Sentiment
63 83 74 61
360° View
360° View
55 35 10 27
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
49 73 69 76
Opinions Change
50 22 50 26
Pro Holdings
n/a 80 86 84
Market Pulse
40 86 34 38
Sentiment
63 83 74 61
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
60 55 43 41
Growth
67 37 43 79
Safety Safety
19 4 1 1
Combined
47 7 4 14
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
90 60 56 67
Price vs. Earnings (P/E)
31 84 82 62
Price vs. Book (P/B)
42 24 15 18
Dividend Yield
1 1 1 1
Value
60 55 43 41
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
36 41 28 33
Profit Growth
98 47 47 64
Capital Growth
36 37 43 52
Stock Returns
55 47 69 87
Growth
67 37 43 79
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
14 3 4 2
Refinancing
12 4 5 1
Liquidity
70 54 44 37
Safety Safety
19 4 1 1

Similar Stocks

Discover high‑ranked alternatives to IQVIA and broaden your portfolio horizons.

ResMed

NYQ:RMD
Country: USA
Industry: Health Care Equipment
Size: X-Large
Full Stock Analysis

Microsoft

NSQ:MSFT
Country: USA
Industry: Systems Software
Size: XX-Large
Full Stock Analysis

Global Payments

NYQ:GPN
Country: USA
Industry: Other Financial Services
Size: X-Large
Full Stock Analysis

Regeneron Pharmaceuticals

NSQ:REGN
Country: USA
Industry: Biotechnology
Size: Large
Full Stock Analysis

Frequently Asked
Questions

This is a high-quality, high-growth stock with positive sentiment. However, the financing is on the riskier side. It is best for a growth-focused investor willing to accept higher financial risk for potentially higher shareholder returns.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews